NeuroOne Medical Technologies (NMTC) Stock Price, News & Analysis

Company Overview

NeuroOne Medical Technologies Corporation, a developmental stage company, provides solutions for EEG recording, brain stimulation and ablation solutions for patients suffering from epilepsy, Parkinson's disease, dystonia, essential tremors, and chronic pain due to failed back surgeries and other related neurological disorders. It also fucuses on applications for other areas, such as depression, mood disorders, pain, incontinence, high blood pressure, and artificial intelligence. It has a strategic partnership with RBC Medical Innovations to develop a radio frequency ablation generator. The company was incorporated in 2009 and is based in Eden Prairie, Minnesota.

Key Stats

• Today's Range: $0.66 to $0.73
• 50-Day Range: $0.66 to $1.02
• 52-Week Range: $0.60 to $2.00
• Volume: 266,106 shs
• Average Volume: 127,906 shs
• Market Capitalization: $22.45 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

NMTC Stock Analysis - Frequently Asked Questions

How have NMTC shares performed this year?

NeuroOne Medical Technologies' stock was trading at $1.58 at the start of the year. Since then, NMTC shares have decreased by 53.9% and is now trading at $0.7288.
View the best growth stocks for 2024 here.

How were NeuroOne Medical Technologies' earnings last quarter?

NeuroOne Medical Technologies Co. (NASDAQ:NMTC) announced its earnings results on Tuesday, February, 13th. The company reported ($0.14) EPS for the quarter. The company earned $0.98 million during the quarter. NeuroOne Medical Technologies had a negative trailing twelve-month return on equity of 276.12% and a negative net margin of 308.51%.

Who are NeuroOne Medical Technologies' major shareholders?

Top institutional investors of NeuroOne Medical Technologies include Geode Capital Management LLC (0.92%) and XTX Topco Ltd (0.09%). Insiders that own company stock include Mark Christianson, Ronald W Mcclurg and Christopher Volker.
View institutional ownership trends.

How do I buy shares of NeuroOne Medical Technologies?

Shares of NMTC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

What other stocks do shareholders of NeuroOne Medical Technologies own?

Based on aggregate information from My MarketBeat watchlists, some other companies that NeuroOne Medical Technologies investors own include Schwab US Large-Cap ETF (SCHX), NVIDIA (NVDA), Advanced Micro Devices (AMD), NIO (NIO), Ford Motor (F), Meta Platforms (META) and Plug Power (PLUG).

Company Calendar

• Last Earnings: 2/13/2024
• Today: 11/21/2024
• Next Earnings (Estimated): 12/12/2024
• Fiscal Year End: 9/30/2025

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Medical
• Industry: Surgical & medical instruments
• Sub-Industry: N/A
• Current Symbol: NASDAQ:NMTC
• CUSIP: N/A
• CIK: 1500198
• Web: www.originalsourcemusic.com
• Phone: (952) 426-1383
• Fax: N/A
• Employees: 16
• Year Founded: N/A

Profitability

• EPS (Most Recent Fiscal Year): ($0.48)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: $-11,860,000.00
• Net Margins: -308.51%
• Pretax Margin: -308.49%
• Return on Equity: -276.12%
• Return on Assets: -199.83%

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: 2.42
• Quick Ratio: 1.36

Sales & Book Value

• Annual Sales: $1.95 million
• Price / Sales: 11.52
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: $0.26 per share
• Price / Book: 2.80

Miscellaneous

• Outstanding Shares: 30,810,000
• Free Float: 28,501,000
• Market Cap: $22.45 million
• Optionable: Optionable
• Beta: 0.73